Bernstein SocGen Group has revised its target price for Amrize Ltd (NYSE:AMRZ) upward to $75 from $70, while maintaining an Outperform rating on the shares. The raised target now sits with the highest analyst price outlook reported for the company, which had a market capitalization of $35.8 billion at the time of reporting. Amrize shares were trading at $63.70, roughly 1.7% below their 52-week high of $64.83.
The firm pointed to Amrize’s fiscal 2026 guidance as the central rationale for the price-target increase. Management’s guidance calls for revenue growth of 4% to 6% and EBITDA growth of 8% to 11% for fiscal 2026, both measures the research team described as constructive and ahead of expectations. The company specifically anticipates 8% to 11% EBITDA expansion in each of its Building Materials and Building Envelope divisions.
Over the trailing twelve months, Amrize reported $11.8 billion in revenue and $2.8 billion in EBITDA. Bernstein noted that the guidance figures include the recently acquired PB Materials business but exclude the impact of any further potential acquisitions. In its commentary, the firm also referenced pricing assumptions embedded in the guidance - management projects low single-digit pricing for cement and mid-single-digit pricing for aggregates.
Bernstein highlighted that many U.S. peers had issued disappointing fiscal 2026 guidance in recent weeks, a dynamic that pressured Amrize shares. In contrast, the company’s stronger-than-expected guidance and a positive surprise on shareholder returns helped the stock recover some of that weakness.
On the drivers behind the guidance, Bernstein said it views the targets as achievable, particularly if margin expansion from the company’s ASPIRE program materializes and operating leverage comes through as volumes recover. The note points to a P/E of 26.7 and street analysts’ consensus earnings per share estimate of $2.77 for fiscal 2026. Taken together, Bernstein observed that Amrize appears to be trading near its InvestingPro Fair Value, suggesting the market has already priced in much of the positive outlook.
Separately, Amrize has completed its acquisition of PB Materials Holdings, Inc., a West Texas operator focused on aggregates and ready-mix concrete. The addition brings 26 operational sites into Amrize’s network and expands the company’s footprint across Texas and the broader Southern region.
The company also disclosed a regulatory safety matter: the Mine Safety and Health Administration issued an imminent danger order at Amrize’s Ravena cement plant in New York related to a safety concern involving a third-party driver. No injuries were reported, and the incident was filed with the U.S. Securities and Exchange Commission.
Other analyst activity noted in the market commentary included BofA Securities raising its target on Amrize to $58 from $55 while maintaining a Neutral rating; that revision reflects adjusted estimates that incorporate expectations for slightly lower EBITDA in the Building Envelope division. The coverage commentary also referenced Bernstein SocGen Group’s prior reiteration of an Outperform rating with a $70 price target following the PB Materials acquisition.
InvestingPro data was cited as showing several positive indicators for Amrize, with seven additional ProTips available for subscribers seeking deeper financial insight. The research note emphasized that the guidance assumes certain pricing and operational improvements and that the market reaction to peer guidance has already influenced Amrize’s recent price action.
In sum, Bernstein’s move to a $75 target rests on management’s fiscal 2026 guidance, the expected benefits of the ASPIRE program and operating leverage, and the integration of PB Materials into Amrize’s network. At the same time, the company faces active regulatory scrutiny in at least one site and ongoing analyst debate over segment-level EBITDA expectations.